Introduction to the Facility

Capable of in-house production of various long-acting microsphere injectable drugs, the facility can expedite the drugs’ clinical trials.

Standards-Compliant Facility
GMP-Compliant Facility
Capable of manufacturing variouslong-acting microsphere injectables
Using our proprietary InnoLAMP technology platform, our manufacturing facility is capable of producing long-acting microsphere injectables applying a variety of APIs.
Ensuring quality uniformity through automated processes
Minimizing human error and ensuring quality uniformity through the application of automated processes
Production capability andquality system secured
Production capability and quality system for early commercial production secured